Article info

Download PDFPDF
Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles
  1. Correspondence to:
 Dr Jeremy Hobart, Department of Clinical Neurosciences, Derriford Hospital, Plymouth, Devon PL8 8DH, UK; 
 jeremy.hobart{at}phnt.swest.nhs.uk
View Full Text

Citation

Riazi A, Hobart JC, Lamping DL, et al
Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles

Publication history

  • Received April 17, 2002
  • Accepted January 15, 2003
  • Revised January 10, 2003
  • First published June 1, 2003.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.